Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates)
Código 350790 (Harmonized System 2012 by 6 digits)
2024: US$203M, Total Trade Exchange
2024: US$40.1M, International Sales
2024: US$163M, International Purchases
Código 350790 (Harmonized System 2012 by 6 digits)
2024: US$203M, Total Trade Exchange
2024: US$40.1M, International Sales
2024: US$163M, International Purchases
In 2024, the trade exchange (includes international purchases and sales) of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) was US$203M.
In 2024, the states with the most international sales in Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were Estado de México (US$19.6M), Ciudad de México (US$14.9M), Querétaro (US$463k), Jalisco (US$400k), and Coahuila de Zaragoza (US$322k).
The states with the most international purchases in 2024 were Ciudad de México (US$63.9M), Jalisco (US$44.9M), Estado de México (US$22M), Querétaro (US$12.2M), and Coahuila de Zaragoza (US$5.05M).
In 2024, the main commercial destinations of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were United States (US$19.4M), Ireland (US$6.43M), Brazil (US$1.48M), Guatemala (US$1.41M), and India (US$865k).
The main commercial origins of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) in 2024 were Denmark (US$56.8M), United States (US$42.5M), China (US$16.6M), France (US$9.84M), and Finland (US$5.1M).
In the global context, the main exporting countries of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) in 2022 were Denmark (US$1.51B), United States (US$975M), and China (US$624M). In the same year, the main importing countries of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were United States (US$1.17B), Germany (US$569M), and Netherlands (US$529M).
US$203M, Total Trade Exchange (2024)
In 2024, the total trade exchange of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) in Mexico (including international purchases and sales) was US$203M.
The visualizations show the net balance of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
March, 2025
In March 2025, international sales of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were US$4.39M, while international purchases reached US$12.2M. The above results in a trade balance of -US$7.85M.
2025-Q1: US$7.83M, International Sales
The visualization shows the quarterly concentration of international sales of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) at state level.
In the first quarter of 2025, international sales were US$7.83M, being the states with the most sales Estado de México (US$6.58M) and Ciudad de México (US$1.25M).
Estado de México: US$19.6M, State with the Most International Sales (2024)
United States: US$19.4M, Main commercial destination (2024)
In 2024, the states with the highest international sales in Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were Estado de México (US$19.6M), Ciudad de México (US$14.9M), Querétaro (US$463k), Jalisco (US$400k), and Coahuila de Zaragoza (US$322k).
In 2024, the countries with the most international purchases from Mexico were United States (US$19.4M), Ireland (US$6.43M), Brazil (US$1.48M), Guatemala (US$1.41M), and India (US$865k).
Ciudad de México: US$63.9M, State with the Most International Purchases (2024)
Denmark: US$56.8M, Main Commercial Origin (2024)
In 2024, the states with the highest international in Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were Ciudad de México (US$63.9M), Jalisco (US$44.9M), Estado de México (US$22M), Querétaro (US$12.2M), and Coahuila de Zaragoza (US$5.05M).
The countries with the most international sales to Mexico in 2024 were Denmark (US$56.8M), United States (US$42.5M), China (US$16.6M), France (US$9.84M), and Finland (US$5.1M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were Denmark (US$1.51B), United States (US$975M), and China (US$624M). In the same year, the main importing countries for Enzymes and Enzyme Preparations, N.E.C. (Exc. Rennet and Concentrates) were United States (US$1.17B), Germany (US$569M), and Netherlands (US$529M).